Pzena Investment Management LLC buys shares of 1,157,273 Envista Holdings Corporation $NVST. August 18, 2026 Key points. * Pzena Investment Management initiated a 1.16 million-share stake in Envista, valued at approximately $30.5 million and representing about 0.71% of the company. * Analyst sentiment is moderately positive: Envista has a consensus "Moderate Buy" rating and an average price target of $29.31, with recent target increases from Piper Sandler and JPMorgan. * Envista exceeded quarterly expectations, reporting $0.41 in EPS versus $0.34 expected and $730.5 million in revenue. Sales rose 7.1% year over year, while full-year EPS guidance stands at $1.50-$1.55. * Five stocks to consider instead of Envista. Pzena Investment Management LLC bought a new stake in Envista Holdings Corporation (NYSE:NVST - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,157,273 shares of the company's stock, valued at approximately $30,494,000. Pzena Investment Management LLC owned approximately 0.71% of Envista at the end of the most recent reporting period. A number of other institutional investors have also recently made changes to their positions in NVST. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Envista in the 2nd quarter valued at $25,000. Caitong International Asset Management Co. Ltd boosted its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock worth $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its stake in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company's stock worth $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company's stock worth $44,000 after buying an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after buying an additional 949 shares in the last quarter. Analyst ratings changes. Several equities analysts have recently weighed in on NVST shares. Piper Sandler reissued a "neutral" rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. Evercore reiterated an "outperform" rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on shares of Envista from $26.00 to $29.00 and gave the stock a "neutral" rating in a research note on Thursday, May 7th. Morgan Stanley set a $23.00 target price on shares of Envista in a research note on Thursday, August 6th. Finally, Zacks Research upgraded Envista from a "hold" rating to a "strong-buy" rating in a research report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $29.31. Discover more Insider trades screener Stock ratings screener Dividend screener tool Envista price performance. NYSE:NVST opened at $27.68 on Tuesday. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The stock's fifty day moving average is $26.66 and its two-hundred day moving average is $26.19. The company has a market capitalization of $4.45 billion, a P/E ratio of 47.72, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analysts' expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company's revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year. Envista profile. Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software. Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments. Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Envista, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list. While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Wall Street analysts have issued bearish price targets for several stocks, signalling serious concerns about their prospects. StockStory conducted independent analysis to identify buying opportunities and companies to avoid. The firm recommends avoiding Envista Holdings, a global dental products company. Its revenue grew just 3.4% annually over five years, whilst earnings per share fell 7% annually. Negative returns on capital suggest growth strategies have backfired. StockStory also advises caution on OneMain Holdings, which provides personal loans to nonprime consumers. Despite 5.5% annual revenue growth over five years, earnings per share declined 9.3% annually. The firm identifies Oscar Health, a technology-focused health insurance company founded in 2012, as a potential buying opportunity despite Wall Street's pessimism.